West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

WST's HVP growth, wider margins and raised 2026 outlook support its recent rally, but a premium valuation raises the bar for further gains.

ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.

Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

All three segments post growth with record quarterly revenue, but margin declines and operational challenges in beauty and closures temper the outlook.

AptarGroup (NYSE:ATR) reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this

Moby summary of AptarGroup, Inc.'s Q2 2026 earnings call

AptarGroup (ATR) delivered earnings and revenue surprises of +5.97% and +2.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) recently reaffirmed its shareholder return policy by declaring a quarterly cash dividend of $0.48 per share, payable on August 20, 2026, to investors of record as of July 30. See our latest analysis for AptarGroup. AptarGroup’s recent dividend decision sits alongside a steady run in the stock, with a 30 day share price return of 5.87% and a year to date share price return of 8.84%, even as the 1 year total shareholder return declined 14.99% and the 3 year total shareholder...

AptarGroup stock is caught between two valuation signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from the current US$133.37 share price, while earnings-based multiples suggest the stock is trading on the expensive side and recent returns over the past year have been weak. Over the past 1 year, AptarGroup has delivered a return of 15.0% in the red, which raises questions about how much confidence the market currently has in the company at this...

SON's Q2 earnings beat on pricing and productivity gains, while sales slip as the ThermoSafe divestiture and softer volumes weigh on sales.

PKG's Q2 earnings beat estimates as record corrugated shipments and the Greif acquisition boost volumes despite pricing pressure and higher costs.

AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Crown Holdings' Q2 earnings beat estimates as beverage can volumes rise 5%. It raises the 2026 adjusted EPS outlook to $8.30-$8.50.

AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Packaging and forest products companies face lackluster demand and weak volumes outside beverage can